Primary Amyloidosis — Trials

Primary Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

106 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06769555	BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy	withdrawn	N/A	0	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	0	Apr 29, 2026	clinicaltrials
NCT05486481	Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)	withdrawn	Phase 1 / Phase 2	0	Alfred Chung, MDOTHER	0	Mar 6, 2025